Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Company 'Latvijas Gāze' is reluctant to easily part with the one and a half million lati fine imposed by the Competition Council.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Aigars Kalvītis is Chairman of the Board
Recent Videos
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper
Suggestions
00:10:00
Kiliaro CEO Elie Komo on Nasdaq First North Listing and the Future of Social Photo Sharing | Elie Komo, CEO, Kiliaro Group AB.
00:10:00
"Empowering Startups: How Iris Capital Partners' Iris Fund Provides Autonomy and Growth Opportunities Through Venture Debt Financing"
00:10:00
Working with 1Spatial | Claire Milverton, CEO, 1Spatial PLCSPA:LSE
00:10:00
The Jason Sissel Matter: 2023 Robert M. Dell Prize for Extraordinary Public Service | Dana Latham - Founder of Latham & Watkins
00:10:00
Globe President and CEO Ernest Cu received a prestigious Lifetime Achievement and Contribution award for his contributions to the telecom industry.
00:10:00
Brian Porter Discusses Q4 Earnings Drivers and Global Economic Outlook | Brian Porter, CEO, Scotiabank.
00:10:00
David Elberstein on the Shifting Identity of the October 8th Jew|David L. Bernstein, Professor, George Mason University School of Law
00:10:00
Creating a Family Mission Statement
00:10:00
Experience the Drillmore difference| Babak Bemani , Chief Executive Officer at Drillmore
00:10:00
Understanding 'How Much is Enough' for Financial Independence with HSC Wealth Advisors
00:10:00
Insights into the Equities Market: Cristina S. Ulang
00:10:00
Partnerships with Industry and Venture Capitalist Firms: DDI partners with pharmaceutical, biotech and venture capital companies to bridge the gap|David E Cohn, MD , CEO OF OSU DRUG DEVELOPMENT INSTITUTE